Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Mycophenolic acid
Mycophenolic acid
Routinely available
Local application
01/02/2023
Indication
Systemic treatment of uveitis
Therapeutic Area
Eye
Status Description
Routinely available in line with local or regional guidance
Formulation
360mg gastro-resistant tablets
Comments
February 2023 - Routinely available in line with local or regional guidance. Included on the ERF for Specialist Initiation. Classified for use under policy for the use of unlicensed medicines.